These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1508223)

  • 21. Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization.
    Rosa S; Biason-Lauber A; Mongan NP; Navratil F; Schoenle EJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4378-82. PubMed ID: 12213902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single amino acid substitution (Met786----Val) in the steroid-binding domain of human androgen receptor leads to complete androgen insensitivity syndrome.
    Nakao R; Haji M; Yanase T; Ogo A; Takayanagi R; Katsube T; Fukumaki Y; Nawata H
    J Clin Endocrinol Metab; 1992 May; 74(5):1152-7. PubMed ID: 1569163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eight novel mutations of the androgen receptor gene in patients with androgen insensitivity syndrome.
    Chávez B; Méndez JP; Ulloa-Aguirre A; Larrea F; Vilchis F
    J Hum Genet; 2001; 46(10):560-5. PubMed ID: 11587068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two de novo mutations in the AR gene cause the complete androgen insensitivity syndrome in a pair of monozygotic twins.
    Mongan NP; Jääskeläinen J; Green K; Schwabe JW; Shimura N; Dattani M; Hughes IA
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1057-61. PubMed ID: 11889162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential splicing of human androgen receptor pre-mRNA in X-linked Reifenstein syndrome, because of a deletion involving a putative branch site.
    Ris-Stalpers C; Verleun-Mooijman MC; de Blaeij TJ; Degenhart HJ; Trapman J; Brinkmann AO
    Am J Hum Genet; 1994 Apr; 54(4):609-17. PubMed ID: 8128958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotype versus phenotype in families with androgen insensitivity syndrome.
    Boehmer AL; Brinkmann O; Brüggenwirth H; van Assendelft C; Otten BJ; Verleun-Mooijman MC; Niermeijer MF; Brunner HG; Rouwé CW; Waelkens JJ; Oostdijk W; Kleijer WJ; van der Kwast TH; de Vroede MA; Drop SL
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4151-60. PubMed ID: 11549642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro.
    Holterhus PM; Werner R; Struve D; Hauffa BP; Schroeder C; Hiort O
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):457-63. PubMed ID: 16151980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased expression of IGF-II and its binding protein, IGF-binding protein-2, in genital skin fibroblasts of patients with complete androgen insensitivity syndrome compared with normally virilized males.
    Elmlinger MW; Mayer I; Schnabel D; Schuett BS; Diesing D; Romalo G; Wollmann HA; Weidemann W; Spindler KD; Ranke MB; Schweikert HU
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4741-6. PubMed ID: 11600534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single amino acid substitution (gly743 --> val) in the steroid-binding domain of the human androgen receptor leads to Reifenstein syndrome.
    Nakao R; Yanase T; Sakai Y; Haji M; Nawata H
    J Clin Endocrinol Metab; 1993 Jul; 77(1):103-7. PubMed ID: 8325932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional characterisation of a natural androgen receptor missense mutation (N771H) causing human androgen insensitivity syndrome.
    Cai J; Cai LQ; Hong Y; Zhu YS
    Andrologia; 2012 May; 44 Suppl 1():523-9. PubMed ID: 21950590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a critical novel mutation in the exon 1 of androgen receptor gene in 2 brothers with complete androgen insensitivity syndrome.
    Radpour R; Falah M; Aslani A; Zhong XY; Saleki A
    J Androl; 2009; 30(3):230-2. PubMed ID: 19023143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Identification of a novel frameshift mutation of human androgen receptor gene in a patient featuring complete androgen insensitivity syndrome].
    Xie JH; Qu JH; Xiao QZ; Zhou YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):99-101. PubMed ID: 23450491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete testicular feminization caused by an amino-terminal truncation of the androgen receptor with downstream initiation.
    Zoppi S; Wilson CM; Harbison MD; Griffin JE; Wilson JD; McPhaul MJ; Marcelli M
    J Clin Invest; 1993 Mar; 91(3):1105-12. PubMed ID: 8450040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel mutation in the ligand-binding domain of the androgen receptor gene (l790p) associated with complete androgen insensitivity syndrome.
    Raicu F; Giuliani R; Gatta V; Palka C; Franchi PG; Lelli-Chiesa P; Tumini S; Stuppia L
    Asian J Androl; 2008 Jul; 10(4):687-91. PubMed ID: 18097502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An androgen receptor mutation in the direct vicinity of the proposed C-terminal alpha-helix of the ligand binding domain containing the AF-2 transcriptional activating function core is associated with complete androgen insensitivity.
    Peters I; Weidemann W; Romalo G; Knorr D; Schweikert HU; Spindler KD
    Mol Cell Endocrinol; 1999 Feb; 148(1-2):47-53. PubMed ID: 10221770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes.
    Elhaji YA; Wu JH; Gottlieb B; Beitel LK; Alvarado C; Batist G; Trifiro MA
    Mol Endocrinol; 2004 Aug; 18(8):1876-86. PubMed ID: 15118070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.
    Shkolny DL; Beitel LK; Ginsberg J; Pekeles G; Arbour L; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 1999 Feb; 84(2):805-10. PubMed ID: 10022458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoreactive AR and genetic alterations in subjects with androgen resistance and undetectable AR levels in genital skin fibroblast ligand-binding assays.
    Avila DM; Wilson CM; Nandi N; Griffin JE; McPhaul MJ
    J Clin Endocrinol Metab; 2002 Jan; 87(1):182-8. PubMed ID: 11788645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of a mutant androgen receptor offers a treatment modality in a patient with partial androgen insensitivity syndrome.
    Radmayr C; Culig Z; Hobisch A; Corvin S; Bartsch G; Klocker H
    Eur Urol; 1998; 33(2):222-6. PubMed ID: 9519369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human complete androgen insensitivity with normal dihydrotestosterone receptor binding capacity in cultured genital skin fibroblasts: evidence for a qualitative abnormality of the receptor.
    Brown TR; Maes M; Rothwell SW; Migeon CJ
    J Clin Endocrinol Metab; 1982 Jul; 55(1):61-9. PubMed ID: 7076808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.